1. Home
  2. CLGN vs PRPH Comparison

CLGN vs PRPH Comparison

Compare CLGN & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • PRPH
  • Stock Information
  • Founded
  • CLGN 2004
  • PRPH 1989
  • Country
  • CLGN Israel
  • PRPH United States
  • Employees
  • CLGN N/A
  • PRPH N/A
  • Industry
  • CLGN Industrial Specialties
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLGN Health Care
  • PRPH Health Care
  • Exchange
  • CLGN Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • CLGN 19.1M
  • PRPH 17.7M
  • IPO Year
  • CLGN N/A
  • PRPH 1997
  • Fundamental
  • Price
  • CLGN $2.31
  • PRPH $0.47
  • Analyst Decision
  • CLGN Strong Buy
  • PRPH
  • Analyst Count
  • CLGN 2
  • PRPH 0
  • Target Price
  • CLGN $11.50
  • PRPH N/A
  • AVG Volume (30 Days)
  • CLGN 69.8K
  • PRPH 882.3K
  • Earning Date
  • CLGN 08-19-2025
  • PRPH 08-13-2025
  • Dividend Yield
  • CLGN N/A
  • PRPH N/A
  • EPS Growth
  • CLGN N/A
  • PRPH N/A
  • EPS
  • CLGN N/A
  • PRPH N/A
  • Revenue
  • CLGN $2,472,000.00
  • PRPH $5,845,000.00
  • Revenue This Year
  • CLGN $1,999.42
  • PRPH $221.82
  • Revenue Next Year
  • CLGN $69.81
  • PRPH N/A
  • P/E Ratio
  • CLGN N/A
  • PRPH N/A
  • Revenue Growth
  • CLGN N/A
  • PRPH N/A
  • 52 Week Low
  • CLGN $1.31
  • PRPH $0.22
  • 52 Week High
  • CLGN $5.45
  • PRPH $3.37
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 65.19
  • PRPH 63.66
  • Support Level
  • CLGN $2.16
  • PRPH $0.32
  • Resistance Level
  • CLGN $2.28
  • PRPH $0.45
  • Average True Range (ATR)
  • CLGN 0.18
  • PRPH 0.04
  • MACD
  • CLGN 0.11
  • PRPH 0.00
  • Stochastic Oscillator
  • CLGN 86.24
  • PRPH 90.27

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: